1. Home
  2. SECZ vs AMPH Comparison

SECZ vs AMPH Comparison

Compare SECZ & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Securitize Corp.

SECZ

Securitize Corp.

N/A

Current Price

$13.95

Market Cap

1.0B

Sector

N/A

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$25.67

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SECZ
AMPH
Founded
2017
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2026
2005

Fundamental Metrics

Financial Performance
Metric
SECZ
AMPH
Price
$13.95
$25.67
Analyst Decision
Buy
Hold
Analyst Count
7
7
Target Price
$13.94
★ $22.50
AVG Volume (30 Days)
★ 3.6M
418.3K
Earning Date
11-20-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.81
Revenue
N/A
★ $719,887,000.00
Revenue This Year
$16.24
$3.87
Revenue Next Year
$72.48
$4.90
P/E Ratio
★ N/A
$33.02
Revenue Growth
★ N/A
N/A
52 Week Low
$5.14
$16.65
52 Week High
$17.00
$29.52

Technical Indicators

Market Signals
Indicator
SECZ
AMPH
Relative Strength Index (RSI) 66.96 61.99
Support Level $5.86 $18.51
Resistance Level N/A $29.40
Average True Range (ATR) 1.42 1.00
MACD 0.39 0.08
Stochastic Oscillator 75.81 51.04

Price Performance

Historical Comparison
SECZ
AMPH

About SECZ Securitize Corp.

Securitize Holdings Inc provides a platform for tokenized real-world assets specializing in tokenizing real-world assets (RWAs) like funds, equities, and fixed income on blockchain networks. The company operates across two primary verticals: i) Tokenization: It consists of on-chain infrastructure and tokenization & distribution, ii) Asset Servicing: It covers post-issuance transfer agent and fund management services. The majority of the company's revenue is derived from the Tokenization vertical.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: